| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Otitis Media | 55 | 1989 | 35 |
Why?
|
Anti-Bacterial Agents | 68 | 1989 | 195 |
Why?
|
Pharyngitis | 53 | 1987 | 14 |
Why?
|
Streptococcus pyogenes | 48 | 1987 | 27 |
Why?
|
Streptococcal Infections | 51 | 1979 | 54 |
Why?
|
Tonsillitis | 31 | 1991 | 10 |
Why?
|
Penicillins | 40 | 1982 | 35 |
Why?
|
Cephalosporins | 35 | 1982 | 22 |
Why?
|
Antibodies, Bacterial | 63 | 1980 | 50 |
Why?
|
Haemophilus influenzae | 45 | 1980 | 39 |
Why?
|
Haemophilus Vaccines | 26 | 1986 | 20 |
Why?
|
Infant | 137 | 1979 | 464 |
Why?
|
Streptococcus pneumoniae | 23 | 1985 | 38 |
Why?
|
Haemophilus Infections | 22 | 1981 | 31 |
Why?
|
Child, Preschool | 116 | 1979 | 555 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 36 | 1986 | 18 |
Why?
|
Bacterial Outer Membrane Proteins | 16 | 1984 | 20 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 16 | 1999 | 9 |
Why?
|
Child | 110 | 1982 | 750 |
Why?
|
Whooping Cough | 20 | 1992 | 14 |
Why?
|
Pneumococcal Infections | 16 | 1981 | 31 |
Why?
|
Humans | 263 | 1978 | 1858 |
Why?
|
Bacterial Vaccines | 22 | 1982 | 27 |
Why?
|
Pertussis Vaccine | 22 | 1979 | 8 |
Why?
|
Immunization, Secondary | 21 | 1979 | 31 |
Why?
|
Amoxicillin | 14 | 1990 | 18 |
Why?
|
Acute Disease | 47 | 1982 | 271 |
Why?
|
Pneumococcal Vaccines | 11 | 1985 | 17 |
Why?
|
Penicillin V | 12 | 1987 | 10 |
Why?
|
Vaccines, Conjugate | 15 | 1997 | 14 |
Why?
|
Polysaccharides, Bacterial | 26 | 1980 | 33 |
Why?
|
Bacterial Infections | 11 | 1982 | 88 |
Why?
|
Meningococcal Vaccines | 9 | 2005 | 11 |
Why?
|
Otitis Media with Effusion | 16 | 1989 | 10 |
Why?
|
Antigens, Bacterial | 15 | 1983 | 44 |
Why?
|
Vaccination | 19 | 1979 | 92 |
Why?
|
Drug Hypersensitivity | 8 | 1979 | 26 |
Why?
|
Respiratory Tract Infections | 11 | 1995 | 57 |
Why?
|
Tetanus Toxoid | 13 | 1985 | 27 |
Why?
|
Viral Vaccines | 15 | 1988 | 35 |
Why?
|
Hepatitis B Vaccines | 9 | 1997 | 17 |
Why?
|
Immunologic Memory | 6 | 1999 | 51 |
Why?
|
Vaccines | 7 | 1989 | 33 |
Why?
|
Nasopharynx | 7 | 1982 | 27 |
Why?
|
Sinusitis | 6 | 1997 | 22 |
Why?
|
Bacterial Proteins | 16 | 1985 | 99 |
Why?
|
Infant, Newborn | 28 | 1979 | 389 |
Why?
|
Adolescent | 50 | 1978 | 892 |
Why?
|
Meningococcal Infections | 5 | 2005 | 9 |
Why?
|
Pediatrics | 11 | 1998 | 133 |
Why?
|
Prospective Studies | 31 | 1987 | 547 |
Why?
|
Fluoroquinolones | 5 | 2005 | 14 |
Why?
|
Female | 95 | 1978 | 1646 |
Why?
|
Physician's Practice Patterns | 7 | 1999 | 149 |
Why?
|
Clinical Trials as Topic | 15 | 1987 | 251 |
Why?
|
Anti-Infective Agents | 6 | 1993 | 54 |
Why?
|
Diphtheria Toxoid | 13 | 1985 | 14 |
Why?
|
Vaccines, Combined | 11 | 1994 | 9 |
Why?
|
Male | 83 | 1971 | 1558 |
Why?
|
Virulence Factors, Bordetella | 13 | 1987 | 22 |
Why?
|
Carrier State | 7 | 1981 | 20 |
Why?
|
Drug Administration Schedule | 24 | 1987 | 193 |
Why?
|
Treatment Outcome | 33 | 1991 | 662 |
Why?
|
Preservatives, Pharmaceutical | 3 | 2002 | 6 |
Why?
|
Thimerosal | 3 | 2002 | 7 |
Why?
|
Drug Resistance, Bacterial | 5 | 2005 | 21 |
Why?
|
United States | 27 | 1992 | 604 |
Why?
|
Recurrence | 24 | 1978 | 261 |
Why?
|
Otolaryngology | 5 | 2000 | 6 |
Why?
|
Mercury | 3 | 2002 | 25 |
Why?
|
Treatment Failure | 16 | 1992 | 88 |
Why?
|
Immunoglobulin G | 17 | 1985 | 192 |
Why?
|
Bordetella pertussis | 12 | 1992 | 9 |
Why?
|
Conjunctivitis, Bacterial | 2 | 2010 | 3 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 1990 | 176 |
Why?
|
Poliovirus Vaccine, Inactivated | 6 | 1990 | 5 |
Why?
|
Rotavirus | 13 | 1988 | 13 |
Why?
|
Microbial Sensitivity Tests | 16 | 1983 | 71 |
Why?
|
Double-Blind Method | 31 | 1987 | 274 |
Why?
|
Drug Prescriptions | 4 | 2002 | 35 |
Why?
|
Drug Resistance, Multiple, Bacterial | 6 | 2004 | 12 |
Why?
|
Immunization Schedule | 15 | 1989 | 25 |
Why?
|
Otoscopy | 3 | 2003 | 2 |
Why?
|
Anthrax Vaccines | 2 | 2005 | 2 |
Why?
|
Anthrax | 2 | 2005 | 3 |
Why?
|
Patient Compliance | 10 | 1987 | 114 |
Why?
|
Tympanic Membrane | 7 | 1989 | 8 |
Why?
|
Adhesins, Bacterial | 8 | 1994 | 14 |
Why?
|
Paracentesis | 5 | 2001 | 3 |
Why?
|
Papillomavirus Infections | 2 | 2006 | 39 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2006 | 55 |
Why?
|
Practice Guidelines as Topic | 7 | 1999 | 174 |
Why?
|
Rotavirus Vaccines | 9 | 1988 | 9 |
Why?
|
Adult | 38 | 1980 | 1321 |
Why?
|
Azithromycin | 3 | 1993 | 13 |
Why?
|
Otitis Media, Suppurative | 3 | 1989 | 4 |
Why?
|
Serotyping | 15 | 1988 | 26 |
Why?
|
Bacteriological Techniques | 3 | 1979 | 29 |
Why?
|
Serum | 2 | 2010 | 7 |
Why?
|
Antibody Formation | 10 | 1981 | 90 |
Why?
|
Milk, Human | 5 | 1980 | 23 |
Why?
|
Cost of Illness | 3 | 1997 | 54 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 15 | 1980 | 224 |
Why?
|
Physicians, Family | 2 | 2004 | 66 |
Why?
|
Antibodies, Viral | 14 | 1988 | 104 |
Why?
|
Genetic Variation | 2 | 2010 | 92 |
Why?
|
Communicable Disease Control | 2 | 1994 | 20 |
Why?
|
Bacteria | 3 | 1979 | 42 |
Why?
|
Hemagglutinins | 8 | 1987 | 12 |
Why?
|
Polymerase Chain Reaction | 3 | 2003 | 279 |
Why?
|
Middle Ear Ventilation | 4 | 1989 | 9 |
Why?
|
Streptococcus | 3 | 1995 | 34 |
Why?
|
Clinical Competence | 4 | 2001 | 130 |
Why?
|
Penicillin Resistance | 7 | 1987 | 14 |
Why?
|
Diagnostic Errors | 3 | 2001 | 73 |
Why?
|
Haemophilus influenzae type b | 3 | 1997 | 3 |
Why?
|
Rotavirus Infections | 9 | 1988 | 12 |
Why?
|
Moraxella (Branhamella) catarrhalis | 4 | 1995 | 4 |
Why?
|
Breast Feeding | 4 | 1990 | 45 |
Why?
|
Autoimmune Diseases of the Nervous System | 2 | 2004 | 5 |
Why?
|
Communicable Diseases, Emerging | 2 | 2007 | 5 |
Why?
|
Drug Resistance, Microbial | 7 | 1993 | 53 |
Why?
|
beta-Lactams | 2 | 2007 | 5 |
Why?
|
Neisseria meningitidis | 3 | 1985 | 11 |
Why?
|
Cefadroxil | 3 | 1987 | 7 |
Why?
|
Cephalexin | 3 | 2003 | 8 |
Why?
|
Cross Reactions | 8 | 1982 | 65 |
Why?
|
Haemophilus | 1 | 2010 | 4 |
Why?
|
Conserved Sequence | 1 | 2011 | 73 |
Why?
|
Moraxellaceae Infections | 1 | 2010 | 2 |
Why?
|
Azepines | 1 | 2010 | 10 |
Why?
|
Antibodies | 2 | 2002 | 159 |
Why?
|
Vaccines, Synthetic | 9 | 1989 | 30 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 18 |
Why?
|
Human papillomavirus 18 | 2 | 2006 | 1 |
Why?
|
Human papillomavirus 16 | 2 | 2006 | 5 |
Why?
|
Streptococcus agalactiae | 2 | 1998 | 12 |
Why?
|
Mucous Membrane | 2 | 1983 | 37 |
Why?
|
Adjuvants, Immunologic | 3 | 1997 | 73 |
Why?
|
Immunization | 4 | 1985 | 85 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2010 | 51 |
Why?
|
Virus Diseases | 1 | 2009 | 50 |
Why?
|
Ambulatory Care | 2 | 1997 | 106 |
Why?
|
Patient Selection | 2 | 2000 | 156 |
Why?
|
Bacterial Toxins | 2 | 2005 | 24 |
Why?
|
New York | 12 | 1984 | 425 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2011 | 113 |
Why?
|
Immunity | 3 | 1992 | 46 |
Why?
|
Education, Medical, Continuing | 3 | 2001 | 54 |
Why?
|
Age Factors | 12 | 1984 | 480 |
Why?
|
Video Recording | 2 | 2002 | 46 |
Why?
|
Hemolysin Proteins | 1 | 2007 | 11 |
Why?
|
Leukocyte Count | 2 | 2003 | 94 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 55 |
Why?
|
Follow-Up Studies | 11 | 1985 | 554 |
Why?
|
Diagnosis, Differential | 8 | 1978 | 403 |
Why?
|
Multilocus Sequence Typing | 3 | 2010 | 5 |
Why?
|
Papillomavirus Vaccines | 1 | 2007 | 19 |
Why?
|
Antibody Affinity | 4 | 1999 | 11 |
Why?
|
Severity of Illness Index | 7 | 1996 | 359 |
Why?
|
Self Efficacy | 1 | 2006 | 27 |
Why?
|
Education, Continuing | 2 | 2001 | 7 |
Why?
|
Time Factors | 14 | 1973 | 896 |
Why?
|
Fever | 5 | 1979 | 66 |
Why?
|
Diphtheria | 6 | 1979 | 7 |
Why?
|
Tetanus | 6 | 1979 | 11 |
Why?
|
Infant, Premature | 4 | 1995 | 70 |
Why?
|
Poliovirus Vaccine, Oral | 6 | 1990 | 8 |
Why?
|
Immunization, Passive | 4 | 1984 | 39 |
Why?
|
beta-Lactamases | 4 | 1997 | 8 |
Why?
|
Retrospective Studies | 8 | 1989 | 656 |
Why?
|
Streptococcal Vaccines | 1 | 2004 | 3 |
Why?
|
Administration, Oral | 11 | 1988 | 170 |
Why?
|
Educational Measurement | 2 | 2001 | 60 |
Why?
|
Immunoglobulin E | 4 | 1998 | 28 |
Why?
|
Single-Blind Method | 6 | 1994 | 86 |
Why?
|
Professional Competence | 1 | 2004 | 37 |
Why?
|
Managed Care Programs | 1 | 2005 | 50 |
Why?
|
Macrolides | 4 | 1995 | 9 |
Why?
|
Immunoassay | 2 | 1999 | 33 |
Why?
|
Sensitivity and Specificity | 6 | 1999 | 427 |
Why?
|
Osteopathic Medicine | 1 | 2003 | 1 |
Why?
|
DNA, Bacterial | 4 | 1995 | 67 |
Why?
|
Peptide Fragments | 1 | 2005 | 145 |
Why?
|
Health Care Costs | 3 | 1997 | 73 |
Why?
|
Skin Tests | 2 | 1998 | 28 |
Why?
|
Erythromycin Ethylsuccinate | 2 | 1983 | 2 |
Why?
|
Drug Therapy, Combination | 4 | 1990 | 189 |
Why?
|
Half-Life | 3 | 2002 | 69 |
Why?
|
Manikins | 4 | 2001 | 5 |
Why?
|
Pharynx | 5 | 1984 | 23 |
Why?
|
Cefaclor | 2 | 1990 | 1 |
Why?
|
Diagnostic Techniques, Otological | 1 | 2001 | 2 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2002 | 19 |
Why?
|
Toxoids | 4 | 1994 | 3 |
Why?
|
Autoimmunity | 1 | 2002 | 27 |
Why?
|
Cefuroxime | 3 | 1987 | 2 |
Why?
|
Attitude to Health | 2 | 1999 | 107 |
Why?
|
Virulence | 4 | 1982 | 48 |
Why?
|
Nurse Practitioners | 1 | 2001 | 27 |
Why?
|
Bacterial Capsules | 8 | 1986 | 16 |
Why?
|
Cohort Studies | 4 | 2002 | 333 |
Why?
|
Family Practice | 3 | 1992 | 84 |
Why?
|
Immunity, Maternally-Acquired | 3 | 1985 | 12 |
Why?
|
Immunoglobulin A | 10 | 1980 | 39 |
Why?
|
Injections, Intramuscular | 3 | 1994 | 44 |
Why?
|
Confidence Intervals | 5 | 1995 | 104 |
Why?
|
Ophthalmic Solutions | 2 | 2010 | 12 |
Why?
|
Bacterial Typing Techniques | 3 | 2005 | 15 |
Why?
|
Streptolysins | 2 | 2009 | 10 |
Why?
|
Diarrhea, Infantile | 2 | 1990 | 11 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 4 | 1990 | 3 |
Why?
|
Drug Utilization | 3 | 1999 | 32 |
Why?
|
Fimbriae, Bacterial | 6 | 1982 | 5 |
Why?
|
Seasons | 4 | 1998 | 64 |
Why?
|
Sequence Analysis, DNA | 2 | 2010 | 111 |
Why?
|
Adenoviridae | 4 | 2005 | 60 |
Why?
|
South Africa | 3 | 2002 | 4 |
Why?
|
Latex Fixation Tests | 3 | 1992 | 16 |
Why?
|
Lipoproteins | 2 | 2009 | 52 |
Why?
|
Carrier Proteins | 4 | 1986 | 177 |
Why?
|
Enterovirus Infections | 1 | 1998 | 10 |
Why?
|
Internship and Residency | 1 | 2002 | 175 |
Why?
|
Office Visits | 3 | 1992 | 50 |
Why?
|
Evidence-Based Medicine | 3 | 1998 | 125 |
Why?
|
Risk Assessment | 4 | 2003 | 325 |
Why?
|
Botulism | 2 | 2007 | 2 |
Why?
|
Animals | 22 | 1971 | 1032 |
Why?
|
Erythromycin | 3 | 1983 | 18 |
Why?
|
Risk Factors | 8 | 1995 | 557 |
Why?
|
Immunity, Innate | 2 | 2008 | 60 |
Why?
|
Ofloxacin | 2 | 2006 | 4 |
Why?
|
Multivariate Analysis | 3 | 2004 | 227 |
Why?
|
Allergens | 1 | 1998 | 28 |
Why?
|
Vaccines, Inactivated | 5 | 1990 | 15 |
Why?
|
Vaccines, Attenuated | 7 | 1990 | 22 |
Why?
|
Incidence | 3 | 1999 | 337 |
Why?
|
Chi-Square Distribution | 3 | 1997 | 179 |
Why?
|
Age Distribution | 3 | 1999 | 127 |
Why?
|
Pertussis Toxin | 5 | 1987 | 25 |
Why?
|
Drug Combinations | 5 | 1986 | 96 |
Why?
|
Meningitis, Haemophilus | 3 | 1984 | 15 |
Why?
|
Antibody Specificity | 2 | 2005 | 71 |
Why?
|
Immunoenzyme Techniques | 2 | 1992 | 125 |
Why?
|
Placebos | 2 | 2003 | 110 |
Why?
|
Chinchilla | 3 | 2000 | 7 |
Why?
|
Clavulanic Acids | 3 | 1990 | 4 |
Why?
|
Scarlet Fever | 1 | 1995 | 2 |
Why?
|
Acoustic Impedance Tests | 4 | 1989 | 5 |
Why?
|
Vaccines, Acellular | 2 | 2005 | 3 |
Why?
|
Pregnancy | 7 | 1982 | 457 |
Why?
|
Ceftizoxime | 1 | 1994 | 1 |
Why?
|
Observer Variation | 3 | 2001 | 103 |
Why?
|
Child Day Care Centers | 3 | 1984 | 10 |
Why?
|
Greece | 2 | 2003 | 5 |
Why?
|
Staphylococcal Infections | 4 | 1979 | 63 |
Why?
|
Tonsillectomy | 1 | 1994 | 12 |
Why?
|
Infant, Low Birth Weight | 2 | 1995 | 31 |
Why?
|
Feces | 3 | 1990 | 43 |
Why?
|
Deuterium | 1 | 1993 | 12 |
Why?
|
Drug Packaging | 1 | 1993 | 9 |
Why?
|
Polysaccharides | 3 | 1982 | 28 |
Why?
|
Phylogeny | 2 | 2009 | 63 |
Why?
|
Influenza, Human | 2 | 2002 | 94 |
Why?
|
Cost-Benefit Analysis | 3 | 1995 | 118 |
Why?
|
Cefotaxime | 1 | 1993 | 4 |
Why?
|
Water | 1 | 1993 | 85 |
Why?
|
Hypersensitivity | 1 | 1993 | 39 |
Why?
|
Suspensions | 3 | 1993 | 8 |
Why?
|
Parents | 2 | 1993 | 89 |
Why?
|
Mice | 6 | 1998 | 623 |
Why?
|
Immunoglobulin A, Secretory | 3 | 1982 | 11 |
Why?
|
Fetal Blood | 1 | 1992 | 54 |
Why?
|
Botulinum Toxins | 2 | 2007 | 12 |
Why?
|
Dose-Response Relationship, Drug | 4 | 1993 | 431 |
Why?
|
False Negative Reactions | 3 | 1992 | 53 |
Why?
|
Phosphates | 1 | 1992 | 71 |
Why?
|
Disease Susceptibility | 1 | 2011 | 61 |
Why?
|
Risk | 3 | 1984 | 203 |
Why?
|
Exudates and Transudates | 2 | 2006 | 15 |
Why?
|
Chronic Disease | 3 | 1982 | 270 |
Why?
|
Tetanus Antitoxin | 1 | 2011 | 1 |
Why?
|
Diphtheria Antitoxin | 1 | 2011 | 2 |
Why?
|
Fimbriae Proteins | 1 | 2011 | 3 |
Why?
|
Epitopes | 2 | 1992 | 87 |
Why?
|
Polymyxin B | 1 | 2010 | 7 |
Why?
|
Immunoglobulin D | 1 | 2010 | 10 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2011 | 11 |
Why?
|
Oropharynx | 1 | 2010 | 9 |
Why?
|
Immunity, Mucosal | 2 | 2007 | 16 |
Why?
|
Aminoglycosides | 1 | 2010 | 12 |
Why?
|
Administration, Intranasal | 2 | 2007 | 25 |
Why?
|
Diphtheria Toxin | 5 | 1985 | 13 |
Why?
|
Ear, Middle | 1 | 2010 | 11 |
Why?
|
Neutralization Tests | 3 | 1990 | 37 |
Why?
|
Bacterial Adhesion | 2 | 2000 | 19 |
Why?
|
Blood Bactericidal Activity | 2 | 2006 | 13 |
Why?
|
Cluster Analysis | 1 | 2010 | 67 |
Why?
|
Tetanus Toxin | 3 | 1995 | 8 |
Why?
|
Questionnaires | 4 | 1997 | 361 |
Why?
|
Aza Compounds | 1 | 2010 | 13 |
Why?
|
Administration, Topical | 1 | 2010 | 58 |
Why?
|
Computational Biology | 1 | 2011 | 40 |
Why?
|
Infant Food | 1 | 1990 | 13 |
Why?
|
Infant Formula | 1 | 2009 | 8 |
Why?
|
Reproducibility of Results | 3 | 1998 | 392 |
Why?
|
Mutation, Missense | 1 | 2011 | 59 |
Why?
|
Private Practice | 2 | 1999 | 32 |
Why?
|
Diphtheria-Tetanus Vaccine | 2 | 1986 | 3 |
Why?
|
Quinolines | 1 | 2010 | 26 |
Why?
|
Membrane Proteins | 3 | 1982 | 233 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2009 | 11 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 126 |
Why?
|
Pentosephosphates | 2 | 1985 | 3 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 3 |
Why?
|
Process Assessment (Health Care) | 1 | 2008 | 11 |
Why?
|
Models, Immunological | 1 | 2009 | 40 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 163 |
Why?
|
Models, Molecular | 1 | 2011 | 102 |
Why?
|
Bias (Epidemiology) | 1 | 2008 | 35 |
Why?
|
Random Allocation | 5 | 1987 | 160 |
Why?
|
Diet | 1 | 1990 | 87 |
Why?
|
Oligosaccharides | 4 | 1985 | 19 |
Why?
|
Saponins | 1 | 2008 | 6 |
Why?
|
Ethylmercury Compounds | 1 | 2008 | 4 |
Why?
|
Lipid A | 1 | 2008 | 7 |
Why?
|
Aluminum Hydroxide | 1 | 2008 | 9 |
Why?
|
Gastroenteritis | 3 | 1995 | 20 |
Why?
|
beta-Lactam Resistance | 1 | 2008 | 3 |
Why?
|
Delayed-Action Preparations | 1 | 2008 | 31 |
Why?
|
BCG Vaccine | 1 | 2008 | 22 |
Why?
|
Reassortant Viruses | 3 | 1996 | 3 |
Why?
|
Clavulanic Acid | 2 | 1994 | 2 |
Why?
|
Molecular Epidemiology | 1 | 2007 | 7 |
Why?
|
Respiratory Mucosa | 1 | 2009 | 39 |
Why?
|
Absenteeism | 2 | 1997 | 26 |
Why?
|
Monte Carlo Method | 1 | 2008 | 40 |
Why?
|
Outcome and Process Assessment (Health Care) | 1 | 2008 | 63 |
Why?
|
Influenza Vaccines | 1 | 2010 | 70 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 53 |
Why?
|
Corynebacterium diphtheriae | 2 | 1992 | 5 |
Why?
|
Sex Factors | 4 | 1993 | 286 |
Why?
|
Cephaloridine | 1 | 2007 | 2 |
Why?
|
Cefamandole | 1 | 2007 | 3 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2008 | 86 |
Why?
|
Bacillus anthracis | 1 | 2007 | 5 |
Why?
|
Molecular Sequence Data | 4 | 2000 | 404 |
Why?
|
United States Food and Drug Administration | 1 | 2007 | 28 |
Why?
|
Hepatitis A Vaccines | 1 | 2006 | 3 |
Why?
|
Immune Tolerance | 2 | 1985 | 72 |
Why?
|
Th1 Cells | 1 | 2007 | 33 |
Why?
|
Safety | 1 | 2007 | 80 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2006 | 17 |
Why?
|
Primary Prevention | 1 | 2007 | 44 |
Why?
|
Europe | 1 | 2006 | 54 |
Why?
|
Th2 Cells | 1 | 2007 | 36 |
Why?
|
Great Britain | 1 | 2006 | 49 |
Why?
|
Analysis of Variance | 3 | 1989 | 339 |
Why?
|
Meningitis, Meningococcal | 1 | 1985 | 7 |
Why?
|
Meningitis, Pneumococcal | 1 | 1985 | 8 |
Why?
|
Formularies as Topic | 1 | 2005 | 1 |
Why?
|
Case-Control Studies | 3 | 2001 | 284 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 319 |
Why?
|
Spores, Bacterial | 1 | 2005 | 3 |
Why?
|
T-Lymphocytes | 1 | 2009 | 182 |
Why?
|
Middle Aged | 6 | 1982 | 1166 |
Why?
|
Cyclic AMP | 2 | 1972 | 90 |
Why?
|
Mouth Mucosa | 2 | 1984 | 28 |
Why?
|
Anaphylaxis | 1 | 2005 | 17 |
Why?
|
B-Lymphocytes | 1 | 2009 | 134 |
Why?
|
Japan | 1 | 2005 | 25 |
Why?
|
Odds Ratio | 1 | 2006 | 157 |
Why?
|
Outcome Assessment (Health Care) | 2 | 2003 | 164 |
Why?
|
Guideline Adherence | 1 | 2005 | 64 |
Why?
|
Gram-Positive Bacteria | 1 | 2004 | 10 |
Why?
|
Behavioral Symptoms | 1 | 2004 | 10 |
Why?
|
Gram-Negative Bacteria | 1 | 2004 | 17 |
Why?
|
Young Adult | 1 | 2008 | 381 |
Why?
|
Nasal Mucosa | 2 | 1981 | 22 |
Why?
|
Publication Bias | 1 | 2004 | 8 |
Why?
|
Community-Acquired Infections | 1 | 2004 | 17 |
Why?
|
Sex Distribution | 1 | 2004 | 101 |
Why?
|
Societies, Medical | 1 | 2005 | 90 |
Why?
|
Child Welfare | 2 | 2000 | 41 |
Why?
|
Italy | 1 | 2003 | 22 |
Why?
|
Epitope Mapping | 2 | 2000 | 21 |
Why?
|
RNA, Bacterial | 1 | 2003 | 34 |
Why?
|
Maternal-Fetal Exchange | 1 | 1984 | 49 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 1990 | 37 |
Why?
|
Medical Records | 2 | 1997 | 105 |
Why?
|
Socioeconomic Factors | 2 | 1984 | 145 |
Why?
|
Immunoglobulin M | 3 | 1982 | 82 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2002 | 7 |
Why?
|
Lipopolysaccharides | 1 | 1984 | 98 |
Why?
|
Family Characteristics | 1 | 2002 | 22 |
Why?
|
Sialic Acids | 1 | 2002 | 17 |
Why?
|
Penicillin G Benzathine | 1 | 2002 | 5 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 219 |
Why?
|
Rheumatic Fever | 1 | 2002 | 9 |
Why?
|
Hepatitis B | 1 | 2002 | 18 |
Why?
|
Influenza B virus | 1 | 2002 | 16 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 189 |
Why?
|
False Positive Reactions | 2 | 1992 | 71 |
Why?
|
Probability | 1 | 2003 | 190 |
Why?
|
Aluminum | 1 | 2002 | 17 |
Why?
|
Drug Resistance | 1 | 2002 | 83 |
Why?
|
Military Medicine | 1 | 2002 | 14 |
Why?
|
Hair | 1 | 2002 | 23 |
Why?
|
Health Care Surveys | 1 | 2003 | 91 |
Why?
|
Genetic Vectors | 3 | 2007 | 139 |
Why?
|
Otoscopes | 1 | 2001 | 1 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 242 |
Why?
|
Lung | 1 | 2009 | 233 |
Why?
|
Videotape Recording | 1 | 2001 | 45 |
Why?
|
Cognition Disorders | 1 | 2004 | 108 |
Why?
|
Osteomyelitis | 1 | 1982 | 39 |
Why?
|
Neisseriaceae Infections | 1 | 2001 | 4 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2002 | 21 |
Why?
|
Professional Practice | 1 | 2001 | 42 |
Why?
|
Physical Examination | 1 | 2001 | 71 |
Why?
|
Costs and Cost Analysis | 1 | 2001 | 71 |
Why?
|
Complement Inactivator Proteins | 1 | 2000 | 8 |
Why?
|
Predictive Value of Tests | 2 | 1999 | 322 |
Why?
|
Meta-Analysis as Topic | 2 | 1990 | 30 |
Why?
|
Drug Costs | 1 | 2000 | 22 |
Why?
|
Meningitis, Bacterial | 1 | 2000 | 9 |
Why?
|
Agglutination Tests | 1 | 2000 | 9 |
Why?
|
Viral Interference | 1 | 2000 | 5 |
Why?
|
Antiviral Agents | 1 | 2002 | 91 |
Why?
|
Family Health | 1 | 2000 | 69 |
Why?
|
Teaching | 1 | 2001 | 90 |
Why?
|
Hepatitis B virus | 1 | 2000 | 8 |
Why?
|
Influenza A virus | 1 | 2002 | 63 |
Why?
|
Drainage | 1 | 2000 | 51 |
Why?
|
Research Design | 1 | 2002 | 169 |
Why?
|
Algorithms | 2 | 2000 | 226 |
Why?
|
Data Collection | 1 | 2000 | 137 |
Why?
|
Genes, Bacterial | 2 | 2009 | 41 |
Why?
|
Reye Syndrome | 1 | 1978 | 5 |
Why?
|
Infant, Newborn, Diseases | 1 | 1979 | 33 |
Why?
|
Epidemiologic Methods | 2 | 1984 | 46 |
Why?
|
Penicillin G | 1 | 1998 | 11 |
Why?
|
Decision Making | 1 | 2000 | 130 |
Why?
|
Sepsis | 1 | 1979 | 73 |
Why?
|
Shock, Septic | 1 | 1998 | 40 |
Why?
|
Animals, Suckling | 1 | 1998 | 6 |
Why?
|
Empiricism | 1 | 1997 | 1 |
Why?
|
Taste | 1 | 1997 | 10 |
Why?
|
Drug Interactions | 1 | 1997 | 111 |
Why?
|
Mice, Inbred BALB C | 2 | 2009 | 176 |
Why?
|
Child Care | 1 | 1997 | 12 |
Why?
|
Drug Therapy | 1 | 1997 | 38 |
Why?
|
Logistic Models | 1 | 1999 | 254 |
Why?
|
Clinical Laboratory Techniques | 1 | 1997 | 31 |
Why?
|
Treatment Refusal | 1 | 1997 | 31 |
Why?
|
Lactams | 1 | 1995 | 6 |
Why?
|
Adhesiveness | 3 | 1982 | 4 |
Why?
|
Poliovirus | 1 | 1995 | 8 |
Why?
|
Cheek | 3 | 1982 | 20 |
Why?
|
Pain | 2 | 1995 | 192 |
Why?
|
Edema | 1 | 1995 | 67 |
Why?
|
Drug Evaluation | 1 | 1994 | 54 |
Why?
|
Prescription Fees | 1 | 1994 | 5 |
Why?
|
Emergency Service, Hospital | 1 | 1997 | 95 |
Why?
|
Remission, Spontaneous | 1 | 1994 | 32 |
Why?
|
Drug Monitoring | 1 | 1994 | 33 |
Why?
|
Bucladesine | 1 | 1973 | 31 |
Why?
|
Deuterium Oxide | 1 | 1993 | 4 |
Why?
|
Hospitalization | 1 | 1997 | 169 |
Why?
|
Cattle | 3 | 1996 | 176 |
Why?
|
Nerve Regeneration | 1 | 1973 | 29 |
Why?
|
Epithelial Cells | 2 | 1982 | 135 |
Why?
|
Suburban Population | 1 | 1993 | 9 |
Why?
|
Cefixime | 1 | 1993 | 1 |
Why?
|
Epithelium | 2 | 1982 | 101 |
Why?
|
Biological Evolution | 1 | 1973 | 32 |
Why?
|
Clostridium tetani | 1 | 1992 | 4 |
Why?
|
Esters | 1 | 1992 | 20 |
Why?
|
Microtubules | 1 | 1973 | 38 |
Why?
|
Enzymes | 1 | 1992 | 22 |
Why?
|
Exotoxins | 1 | 1992 | 9 |
Why?
|
Colostrum | 2 | 1980 | 3 |
Why?
|
Primary Health Care | 1 | 1997 | 151 |
Why?
|
Regression Analysis | 1 | 1993 | 256 |
Why?
|
Clinical Protocols | 1 | 1992 | 93 |
Why?
|
Mumps Vaccine | 1 | 1990 | 6 |
Why?
|
Rubella Vaccine | 1 | 1990 | 9 |
Why?
|
Measles Vaccine | 1 | 1990 | 9 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 1990 | 9 |
Why?
|
Genotype | 1 | 1992 | 175 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 178 |
Why?
|
Cell Movement | 1 | 1973 | 163 |
Why?
|
Sclerosis | 1 | 1989 | 6 |
Why?
|
Audiometry | 1 | 1989 | 11 |
Why?
|
Atrophy | 1 | 1989 | 41 |
Why?
|
Weight Loss | 1 | 1990 | 52 |
Why?
|
Haptens | 1 | 1989 | 10 |
Why?
|
Vaccines, Subunit | 1 | 2009 | 10 |
Why?
|
Therapeutic Equivalency | 1 | 2009 | 9 |
Why?
|
Patient Participation | 1 | 2009 | 40 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2009 | 89 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1990 | 85 |
Why?
|
Pain Measurement | 1 | 2009 | 98 |
Why?
|
Aged | 4 | 1982 | 992 |
Why?
|
Agglutinins | 1 | 1987 | 5 |
Why?
|
DNA Primers | 1 | 2009 | 208 |
Why?
|
Linear Models | 2 | 1995 | 151 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 254 |
Why?
|
Prevalence | 2 | 1992 | 282 |
Why?
|
Disease Models, Animal | 1 | 2011 | 349 |
Why?
|
Hepatitis A | 1 | 2006 | 9 |
Why?
|
Erythrocytes | 2 | 1984 | 110 |
Why?
|
Rats | 3 | 1973 | 532 |
Why?
|
Pregnancy Trimester, Third | 1 | 1985 | 28 |
Why?
|
Animals, Newborn | 1 | 2007 | 175 |
Why?
|
Acetylation | 1 | 1985 | 46 |
Why?
|
Nurseries | 1 | 1984 | 2 |
Why?
|
Rifampin | 1 | 1984 | 12 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2004 | 4 |
Why?
|
Base Sequence | 1 | 2009 | 371 |
Why?
|
Cell Line | 1 | 2009 | 375 |
Why?
|
Temperature | 1 | 1984 | 137 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 168 |
Why?
|
Carbuncle | 1 | 1983 | 1 |
Why?
|
Erythromycin Estolate | 1 | 1983 | 1 |
Why?
|
Furunculosis | 1 | 1983 | 2 |
Why?
|
Pyoderma | 1 | 1983 | 6 |
Why?
|
Disease Outbreaks | 1 | 1984 | 61 |
Why?
|
Disease Transmission, Infectious | 1 | 2002 | 12 |
Why?
|
Zanamivir | 1 | 2002 | 9 |
Why?
|
Pyrans | 1 | 2002 | 11 |
Why?
|
Psychomotor Performance | 1 | 2004 | 70 |
Why?
|
Guanidines | 1 | 2002 | 26 |
Why?
|
Mucus | 1 | 1982 | 11 |
Why?
|
Chemoprevention | 1 | 2002 | 13 |
Why?
|
Neuropsychological Tests | 1 | 2004 | 114 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1984 | 176 |
Why?
|
Proteus Infections | 1 | 1982 | 3 |
Why?
|
Bacteroides Infections | 1 | 1982 | 5 |
Why?
|
Erythrocyte Membrane | 1 | 1982 | 26 |
Why?
|
Nasopharyngeal Diseases | 1 | 1981 | 2 |
Why?
|
Staphylococcus aureus | 1 | 1983 | 48 |
Why?
|
Pneumonia | 1 | 2004 | 85 |
Why?
|
Epiglottis | 1 | 1981 | 2 |
Why?
|
Laryngitis | 1 | 1981 | 3 |
Why?
|
Meningitis | 1 | 1981 | 17 |
Why?
|
Saliva | 1 | 1982 | 61 |
Why?
|
Radioimmunoassay | 1 | 2000 | 82 |
Why?
|
Serologic Tests | 1 | 2000 | 24 |
Why?
|
Immunophenotyping | 1 | 2000 | 66 |
Why?
|
Klebsiella Infections | 1 | 1979 | 2 |
Why?
|
Corynebacterium Infections | 1 | 1979 | 10 |
Why?
|
Escherichia coli Infections | 1 | 1979 | 27 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 156 |
Why?
|
Ornithine Carbamoyltransferase | 1 | 1978 | 5 |
Why?
|
Carnitine | 1 | 1978 | 11 |
Why?
|
Cerumen | 1 | 1998 | 1 |
Why?
|
Bone and Bones | 1 | 1982 | 99 |
Why?
|
Child Behavior | 1 | 1979 | 41 |
Why?
|
Peptides | 1 | 2000 | 154 |
Why?
|
Blotting, Western | 1 | 2000 | 275 |
Why?
|
Nose | 1 | 1997 | 31 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1996 | 13 |
Why?
|
Longitudinal Studies | 1 | 1998 | 195 |
Why?
|
Reference Values | 1 | 1998 | 281 |
Why?
|
Multicenter Studies as Topic | 1 | 1996 | 70 |
Why?
|
Species Specificity | 1 | 1997 | 186 |
Why?
|
Vomiting | 1 | 1995 | 45 |
Why?
|
Educational Status | 1 | 1995 | 99 |
Why?
|
African Continental Ancestry Group | 1 | 1995 | 80 |
Why?
|
Nerve Crush | 1 | 1973 | 6 |
Why?
|
Sciatic Nerve | 1 | 1973 | 25 |
Why?
|
European Continental Ancestry Group | 1 | 1995 | 118 |
Why?
|
Reflex | 1 | 1973 | 33 |
Why?
|
Aged, 80 and over | 1 | 2000 | 602 |
Why?
|
Cytoplasmic Streaming | 1 | 1973 | 2 |
Why?
|
Flagella | 1 | 1973 | 8 |
Why?
|
Pseudopodia | 1 | 1973 | 9 |
Why?
|
Cilia | 1 | 1973 | 10 |
Why?
|
Drug Tolerance | 1 | 1992 | 26 |
Why?
|
Venezuela | 1 | 1992 | 3 |
Why?
|
Mitosis | 1 | 1973 | 68 |
Why?
|
Ganglia | 1 | 1972 | 10 |
Why?
|
Binding, Competitive | 1 | 1992 | 109 |
Why?
|
Muscles | 1 | 1973 | 111 |
Why?
|
Ethnic Groups | 1 | 1993 | 96 |
Why?
|
Ascitic Fluid | 1 | 1971 | 20 |
Why?
|
Centrifugation, Density Gradient | 1 | 1971 | 48 |
Why?
|
Antigens, Viral | 1 | 1992 | 53 |
Why?
|
Peritonitis | 1 | 1971 | 28 |
Why?
|
Macaca mulatta | 1 | 1992 | 71 |
Why?
|
Axons | 1 | 1972 | 67 |
Why?
|
Lymphocytes | 1 | 1971 | 142 |
Why?
|
Carbohydrate Conformation | 1 | 1989 | 8 |
Why?
|
Macrophages | 1 | 1971 | 148 |
Why?
|
Structure-Activity Relationship | 1 | 1989 | 124 |
Why?
|
Immunoglobulins | 1 | 1987 | 54 |
Why?
|
Periodic Acid | 1 | 1986 | 6 |
Why?
|
Hemagglutination | 1 | 1985 | 6 |
Why?
|
Antigens, Surface | 1 | 1985 | 51 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 170 |
Why?
|
Rabbits | 1 | 1985 | 254 |
Why?
|
Phenotype | 1 | 1985 | 304 |
Why?
|
Opsonin Proteins | 1 | 1981 | 12 |
Why?
|
Cell Count | 2 | 1971 | 163 |
Why?
|
Stimulation, Chemical | 1 | 1972 | 42 |
Why?
|
Chick Embryo | 1 | 1972 | 62 |
Why?
|
Mineral Oil | 1 | 1971 | 6 |
Why?
|
Hydrocarbons | 1 | 1971 | 8 |
Why?
|
Computers | 1 | 1971 | 59 |
Why?
|
Methods | 1 | 1971 | 133 |
Why?
|
Guinea Pigs | 1 | 1971 | 77 |
Why?
|
Neutrophils | 1 | 1971 | 114 |
Why?
|
